COMPARISON OF REDUCTION IN MICROALBUMINURIA BY ENALAPRIL AND HYDROCHLOROTHIAZIDE IN NORMOTENSIVE PATIENTS WITH INSULIN-DEPENDENT DIABETES

被引:71
作者
HALLAB, M
GALLOIS, Y
CHATELLIER, G
ROHMER, V
FRESSINAUD, P
MARRE, M
机构
[1] CHU ANGERS,SERV MED B,F-49033 ANGERS 1,FRANCE
[2] CHU ANGERS,BIOCHIM LAB,F-49033 ANGERS,FRANCE
[3] HOP BROUSSAIS,SERV INFORMAT MED,F-75674 PARIS 14,FRANCE
关键词
D O I
10.1136/bmj.306.6871.175
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-To compare the effects of sodium depletion and of angiotensin I converting enzyme inhibition on microalbuminuria in insulin dependent diabetes. Design-Randomised, double blind, double dummy parallel study of normotensive diabetic patients with persistent microalbuminuria (30-300 mg/24 h) treated with enalapril or hydrochlorothiazide for one year after a three month, single blind placebo period. Setting-Diabetic clinic in a tertiary referral centre. Patients-10 diabetic patients with low microalbuminuria (30-99 mg/24 h) and 11 with high microalbuminuria (100-300 mg/24 h). Interventions-11 subjects (six with low microalbuminuria, five with high microalbuminuria) were given enalapril 20 mg plus placebo hydrochlorothiazide once daily and 10 (four with low microalbuminuria, six with high microalbuminuria) hydrochlorothiazide 25 mg plus placebo enalapril once daily. Main outcome measures-Monthly assessment of urinary albumin excretion and mean arterial pressure; plasma active renin and aldosterone concentrations and renal function studies at 0, 6, and 12 months. Results-Median urinary albumin excretion decreased from 59 (range 37-260) to 38 (14-146) mg/24 h with enalapril and from 111 (33-282) to 109 (33-262) mg/24 h with hydrochlorothiazide (analysis of variance, p=0.0436). During the last three months of treatment with enalapril five patients had persistent normoalbuminuria (2-3 times below 30 mg/24 h), five low microalbuminuria, and one high microalbuminuria; in the hydrochlorothiazide group one had normoalbuminuria, three low microalbuminuria, and six high microalbuminuria (chi2 test=6.7; p=0.03). Mean arterial pressure did not differ before (98 (SD 7) with enalapril v 97 (9) mm Hg with hydrochlorothiazide) or during treatment (88 (7) with enalapril v 90 (7) mm Hg with hydrochlorothiazide (analysis of variance, p=0.5263)). Glomerular filtration rate did not vary. The aldosterone to active renin ratio was decreased by angiotensin I converting enzyme inhibition and increased by sodium depletion, showing treatment efficacy. Conclusion-Angiotensin I converting enzyme inhibition by enalapril effectively reduces microalbuminuria in normotensive diabetic patients whereas hydrochlorothiazide is not effective. Changes in blood pressure and activity of the renin-angiotensin-aldosterone system may contribute to these different effects.
引用
收藏
页码:175 / 182
页数:8
相关论文
共 37 条
[11]  
Goldstein DE, 1986, METHODS DIABETES RES, V2, P475
[12]   CONTROL OF GLOMERULAR-FILTRATION RATE BY RENIN-ANGIOTENSIN SYSTEM [J].
HALL, JE ;
GUYTON, AC ;
JACKSON, TE ;
COLEMAN, TG ;
LOHMEIER, TE ;
TRIPPODO, NC .
AMERICAN JOURNAL OF PHYSIOLOGY, 1977, 233 (05) :F366-F372
[13]   RENAL HEMODYNAMICS AND SEGMENTAL TUBULAR REABSORPTION IN EARLY TYPE-1 DIABETES [J].
HANNEDOUCHE, TP ;
DELGADO, AG ;
GNIONSAHE, DA ;
BOITARD, C ;
LACOUR, B ;
GRUNFELD, JP .
KIDNEY INTERNATIONAL, 1990, 37 (04) :1126-1133
[14]   ACUTE REDUCTION OF ARTERIAL BLOOD-PRESSURE REDUCES URINARY ALBUMIN EXCRETION IN TYPE-1 (INSULIN-DEPENDENT) DIABETIC-PATIENTS WITH INCIPIENT NEPHROPATHY [J].
HOMMEL, E ;
MATHIESEN, E ;
EDSBERG, B ;
BAHNSEN, M ;
PARVING, HH .
DIABETOLOGIA, 1986, 29 (04) :211-215
[15]   GLOMERULAR HEMODYNAMICS IN EXPERIMENTAL DIABETES-MELLITUS [J].
HOSTETTER, TH ;
TROY, JL ;
BRENNER, BM .
KIDNEY INTERNATIONAL, 1981, 19 (03) :410-415
[16]  
KEETON TK, 1980, PHARMACOL REV, V32, P81
[17]   ANGIOTENSIN CONVERTING ENZYME-INHIBITION REVEALS AN IMPORTANT ROLE FOR THE RENIN SYSTEM IN THE CONTROL OF NORMAL AND HIGH BLOOD-PRESSURE IN MAN [J].
MACGREGOR, GA ;
MARKANDU, ND ;
SMITH, SJ ;
SAGNELLA, GA ;
MORTON, JJ .
CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1983, 5 (7-8) :1367-1380
[18]   PREVENTION OF DIABETIC NEPHROPATHY WITH ENALAPRIL IN NORMOTENSIVE DIABETICS WITH MICROALBUMINURIA [J].
MARRE, M ;
CHATELLIER, G ;
LEBLANC, H ;
GUYENE, TT ;
MENARD, J ;
PASSA, P .
BMJ-BRITISH MEDICAL JOURNAL, 1988, 297 (6656) :1092-1095
[19]  
MARRE M, 1987, CLIN CHEM, V33, P209
[20]   SMALL DOSES OF RAMIPRIL TO REDUCE MICROALBUMINURIA IN DIABETIC-PATIENTS WITH INCIPIENT NEPHROPATHY INDEPENDENTLY OF BLOOD-PRESSURE CHANGES [J].
MARRE, M ;
HALLAB, M ;
BILLIARD, A ;
LEJEUNE, JJ ;
BLED, F ;
GIRAULT, A ;
FRESSINAUD, P .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 18 :S165-S168